Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: The Bronx NY, Greenwich CT, Stamford CT, Fairfield CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase2, Recruiting
Genomic Profiling in Cancer Patients
for
Solid Tumors, Hematologic Cancers
Location: New York NY, Brooklyn NY, The Bronx NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 0+
Code: NCT01775072
Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Livingston NJ, New Brunswick NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase2, Phase3, Recruiting
Pediatric Vasculitis Initiative
for
Wegeners Granulomatosis (Granulomatosis With Polyangiitis),
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
for
Symptomatic Venous Thromboembolism (VTE)
Location: Teaneck NJ, Baltimore MD, Annapolis MD, Boston MA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07213778
Phase3, Recruiting
Patient-Specific Simulation Used for EVAR Procedure Rehearsal - Evaluation of Clinical Performance With and Without Prior Rehearsal
for
Infra Renal Aortic Aneurysm
Location: Teaneck NJ, Cleveland OH, Columbus OH, Tampa FL,
Sponsor: Simbionix US Corporation
Sex: All
Age: 18+
Code: NCT02151942
Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Hackensack NJ, Teaneck NJ, The Bronx NY,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
for
Hematologic Malignancies,
Location: Hackensack NJ, Baltimore MD, Boston MA, Chapel Hill NC,
Sponsor: Pulmotect, Inc.
Sex: All
Age: 18+
Code: NCT06665100
Phase2, Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Location: Hackensack NJ, East Brunswick NJ, Montreal, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04728893
Phase2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: New York NY, Hackensack NJ, Bronx NY, Bethlehem PA,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Hackensack NJ, Lake Success NY, Charlotte NC,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06697197
Phase1, Phase2, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Hackensack NJ, Charlottesville VA, Edgewood KY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase1, Phase2, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)